Acquisition of Concept Life Sciences
26 January 2018 – Spectris plc (‘Spectris’) (LSE: SXS), the productivity-enhancing instrumentation and controls company, today announces that it has completed the acquisition of Concept Life Sciences from Equistone Partners Europe and company management. The purchase consideration of £163 million, on a debt and cash-free basis, will be met from existing cash and bank facilities.... Read more